Acute effects of rapamycin on glomerular dynamics: A micropuncture study in the rat

被引:24
作者
Sabbatini, M [1 ]
Sansone, G [1 ]
Uccello, F [1 ]
De Nicola, L [1 ]
Nappi, F [1 ]
Andreucci, VE [1 ]
机构
[1] Univ Naples Federico II, Dept Nephrol, I-80123 Naples, Italy
关键词
D O I
10.1097/00007890-200005150-00034
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The acute effects of cyclosporin (CsA, 20 mg/kg i.v.) and rapamycin (RAPA, 5 mg/kg i.v.) on glomerular dynamics were separately investigated by renal micropuncture in two groups of intact rats (group CsA and RAPA, respectively) and compared with vehicle-treated rats, used as controls (group CON). Left kidney glomerular filtration rate (GFR) was decreased by CSA (-35% vs. CON, P<0.05), but was not affected by RAPA (-14% vs. CON, NS), whereas the single-nephron GFR (SNGFR) was significantly decreased in both groups (-40% in CsA, P<0.01 and -26% in RAPA, P<0.05 vs. CON). In both groups glomerular plasma flow (GPF) was significantly reduced vs. CON (CsA: -48%, and RAPA: -25%) due to the increase in both afferent (Ra) and efferent (Re) glomerular resistances: group CSA showed a prevalent rise in Re (+98% vs. CON, P<0.001) than in Ra (+66%, P<0.001); in group RAPA the increment was modest and similar in Ra and Re (+33 and +32%, respectively, NS versus CON). A further group of rats was studied in which L-Arginine (ARG), the precursor of nitric oxide (NO), was administered (2.5 mg/Kg/min iv) with RAPA (group ARG), ARG limited the rise in Ra and Re, thereby preserving GPF; nevertheless, SNGFR remained low (-26% vs. CON, P<0.05) due to the decrease in the effective filtration pressure (-26% vs. CON). These data demonstrate that: (1) CsA is nephrotoxic at immunosuppressive doses; (2) RAPA, even at huge doses, has marginal effects on renal and glomerular dynamics; (3) the ARG-NO pathway is only partially involved in the vasoconstriction of superficial nephrons after RAPA administration.
引用
收藏
页码:1946 / 1949
页数:4
相关论文
共 17 条
[1]   Comparison of acute rapamycin nephrotoxicity with cyclosporine and FK506 [J].
Andoh, TF ;
Burdmann, EA ;
Fransechini, N ;
Houghton, DC ;
Bennett, WM .
KIDNEY INTERNATIONAL, 1996, 50 (04) :1110-1117
[2]   Synergistic effects of cyclosporine and rapamycin in a chronic nephrotoxicity model [J].
Andoh, TF ;
Lindsley, J ;
Franceschini, N ;
Bennett, WM .
TRANSPLANTATION, 1996, 62 (03) :311-316
[3]   Nature and mediators of renal lesions in kidney transplant patients given cyclosporine for more than one year [J].
Benigni, A ;
Bruzzi, I ;
Mister, M ;
Azzollini, N ;
Gaspari, F ;
Perico, N ;
Gotti, E ;
Bertani, T ;
Remuzzi, G .
KIDNEY INTERNATIONAL, 1999, 55 (02) :674-685
[4]   PREVENTION OF EXPERIMENTAL CYCLOSPORINE-INDUCED INTERSTITIAL FIBROSIS BY LOSARTAN AND ENALAPRIL [J].
BURDMANN, EA ;
ANDOH, TF ;
NAST, CC ;
EVAN, A ;
CONNORS, BA ;
COFFMAN, TM ;
LINDSLEY, J ;
BENNETT, WM .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 1995, 269 (04) :F491-F499
[5]   NITRIC-OXIDE AND ANGIOTENSIN-II - GLOMERULAR AND TUBULAR INTERACTION IN THE RAT [J].
DENICOLA, L ;
BLANTZ, RC ;
GABBAI, FB .
JOURNAL OF CLINICAL INVESTIGATION, 1992, 89 (04) :1248-1256
[6]   ARGININE FEEDING MODIFIES CYCLOSPORINE NEPHROTOXICITY IN RATS [J].
DENICOLA, L ;
THOMSON, SC ;
WEAD, LM ;
BROWN, MR ;
GABBAI, FB .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 92 (04) :1859-1865
[7]   THE EFFECT OF RAPAMYCIN ON KIDNEY-FUNCTION IN THE SPRAGUE-DAWLEY RAT [J].
DIJOSEPH, JF ;
SHARMA, RN ;
CHANG, JY .
TRANSPLANTATION, 1992, 53 (03) :507-513
[8]   Immunosuppressive effects and safety of a sirolimus/cyclosporine combination regimen for renal transplantation [J].
Kahan, BD ;
Podbielski, J ;
Napoli, KL ;
Katz, SM ;
Meier-Kriesche, HU ;
Van Buren, CT .
TRANSPLANTATION, 1998, 66 (08) :1040-1046
[9]  
LAFAYETTE RA, 1993, J AM SOC NEPHROL, V3, P1892
[10]   DIETARY SUPPLEMENTATION WITH L-ARGININE AMELIORATES THE PROGRESSION OF RENAL-DISEASE IN RATS WITH SUBTOTAL NEPHRECTOMY [J].
REYES, AA ;
PURKERSON, ML ;
KARL, I ;
KLAHR, S .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1992, 20 (02) :168-176